Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents
- 1 March 1993
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 71 (9) , C12-C22
- https://doi.org/10.1016/0002-9149(93)90082-n
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmiasAmerican Heart Journal, 1992
- Long-term experience with sotalol in the treatment of complex ventricular arrhythmiasAmerican Heart Journal, 1987
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Reversibility of Catecholamine-Induced Dilated Cardiomyopathy in a Child with a PheochromocytomaNew England Journal of Medicine, 1987
- Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.Circulation, 1985
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Reduced aortocoronary sinus extraction of epinephrine in patients with left ventricular failure secondary to long-term pressure or volume overload.Circulation, 1983
- Intravenous Beta-Blockade in Coronary Heart DiseaseNew England Journal of Medicine, 1982
- Sustained Reduction of Cardiac Impedance and Preload in Congestive Heart Failure with the Antihypertensive Vasodilator PrazosinNew England Journal of Medicine, 1977
- Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonistsLife Sciences, 1973